Monopar Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Monopar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monopar Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monopar Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $17M | 208k | 81.67 |
| 2025-06-30 | $3.1M | 87k | 35.78 |
| 2025-03-31 | $2.0M | 55k | 36.41 |
| 2024-12-31 | $1.2M | 57k | 22.00 |